JenaValve Anogadza Kari Moore seMukuru Wezvemari

IRVINE, Calif., Chivabvu 17, 2022 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc. ("JenaValve kana "Company"), mugadziri uye mugadziri weakasiyana transcatheter aortic valve replacement (TAVR) masisitimu, nhasi azivisa kugadzwa kwe Kari Moore seChief Financial Officer wekambani inoshanda Chivabvu 10, 2022. "Tinofara kugamuchira Kari kuchikwata cheJenaValve," akadaro JenaValve CEO John Kilcoyne. maindasitiri ezvehutano. Ruzivo rwakadzama rwaKari uye hunyanzvi hweindasitiri huchatibatsira kuenderera mberi nekuita zano redu rekiriniki uye kusimudzira Trilogy yedu yekurapa aortic valve chirwere ® Commercialization Efforts yeMoyo Valve Systems. Amai Moore vanobatana naJenaValve mushure mekunge vamboshanda seMukuru weAccounting Officer weEnvista Holdings Corporation, kambani yepasi rose yezvigadzirwa zvemazino, kwavaiva nebasa rekuita zveakaunzi pasi rose, zvemari uye mabasa ekugoverana mabasa.Asati ajoina Envista Holdings Corporation, Amai Moore vaiva Mukuru Accounting Officer weApplied Medical Corporation, kambani yepasi rose yezvishandiso zvekurapa inopa matekinoroji nemhinduro dzekuvhiya kushoma uye kwakajairika.Ms. Moore akatanga mashandiro ake paPricewaterhouseCoopers, kwaaishanda seauditor, achinyanya kuita zvesainzi yehupenyu. Mukati mebasa ravo remakore makumi maviri, Amai Moore vakaendesa makambani mazhinji kuruzhinji uye akaabatsira mukutenga, kudhirowa uye kubhadhara zvikwereti. Kari akabata BA muBusiness Administration kubva kuYunivhesiti yeSouthern California uye iri CPA mudunhu reCalifornia. "Ndiri kufara kubatana neJenaValve panguva yakaoma kudaro," akadaro Ms. Moore. "Ndiri kufara kushanda neboka rose reJenaValve sezvatinoramba tichiita pakukura kwedu uye kukoshesa nzira dzekugadzira tichivandudza hupenyu hwevarwere." About JenaValve JenaValve Technology, Inc., ine dzimbahwe kuIrvine, California, ine nzvimbo muLeeds, UK neMunich, Germany, inogadzira uye inogadzira transcatheter aortic valve replacement (TAVR) masisitimu ekurapa varwere vane aortic valve chirwere.JenaValve inotsigirwa ne Bain Capital Life Sciences uye Cormorant Asset Management, pamwe chete nevashambadziri vekuEurope neAsia vanosanganisira Andera Partners, Gimv (Euronext: GIMB), Legend Capital, NeoMed Management, RMM, Valiance Life Sciences, VI Partners uye Peijia Medical Limited (HKEx: 9996) . United States: Chenjerera - Zvekutsvagisa Equipment.Kunorambidzwa nemutemo wemubatanidzwa (kana weUS) wekushandiswa kwetsvakiridzo chete.